C94.02
Acute erythroid leukemia, in relapse
Clinical Classification Guidelines
Medical Intelligence & Overview
Acute erythroid leukemia in relapse, classified under ICD-10 code C94.02, is a rare and aggressive form of blood cancer that affects the erythroid lineage of the bone marrow. This condition involves the uncontrolled proliferation of immature red blood cell precursors, leading to severe disruption in blood cell production. When it relapses, it indicates that the disease has returned after a period of remission, necessitating further medical attention and management. This overview aims to provide a patient-friendly explanation of this complex diagnosis, including its causes, symptoms, diagnostic procedures, and treatment options.
Causes & Symptoms
Clinical Causes: Genetic mutations within hematopoietic stem cells that lead to abnormal cell growth Previous exposure to certain chemotherapy or radiation therapy treatments for other cancers Underlying bone marrow disorders, such as myelodysplastic syndromes Exposure to environmental toxins or chemicals, such as benzene Inherited genetic predispositions that increase risk
Key Symptoms: Signs of anemia, including fatigue and weakness Shortness of breath and pallor Frequent infections due to low white blood cell counts Unusual bleeding or easy bruising resulting from low platelet levels Bone pain or tenderness Unintentional weight loss and night sweats
Diagnostic & Treatment
Diagnosis Path: Blood tests to assess blood cell counts and examine the presence of abnormal cells Bone marrow biopsy and aspiration to evaluate the marrow's cellular composition and identify abnormal erythroid precursors Cytogenetic and molecular testing to detect specific genetic and chromosomal abnormalities associated with the disease Imaging studies, if necessary, to evaluate for organ involvement or other complications Review of patient history, including previous treatments and remission status
Treatment Protocols: Chemotherapy to target and destroy leukemia cells within the bone marrow Targeted therapy, if specific genetic mutations are identified, to inhibit disease progression Blood transfusions to manage anemia and improve blood cell counts Supportive care, including antibiotics for infections and medications to control bleeding Stem cell transplantation, which may offer a potential cure for suitable candidates Clinical trials exploring new treatments and drug combinations
Clinical Advice & FAQs
Billing Guidance
Is C94.02 a billable ICD-10 code?
Yes, C94.02 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C94.02?
Clinical documentation must specify the nature of Acute erythroid leukemia, in relapse and any associated comorbidities for accurate reporting.
Cite this Clinical Reference